Trials / Recruiting
RecruitingNCT06345898
Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)
Clinical Study on the Safety and Efficacy of JWK002 Injection Administered as a Single Subretinal Injection in Subjects With X-linked Retinoschisis
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- Male
- Age
- 5 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is to evaluate the safety and efficacy of JWK002 treatment of X-linked retinoschisis(XLRS). This study will enroll subjects aged 5-18 years old to receive a sub-retinal injection of JWK002.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JWK002 | Subretinal administration of gene therapy vector JWK002 to one eye. |
Timeline
- Start date
- 2023-11-17
- Primary completion
- 2033-11-30
- Completion
- 2033-11-30
- First posted
- 2024-04-03
- Last updated
- 2025-02-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06345898. Inclusion in this directory is not an endorsement.